23
Views
9
CrossRef citations to date
0
Altmetric
Review

Thrombolytic and newer mechanical device treatment for acute ischemic stroke

Pages 1099-1105 | Published online: 10 Jan 2014

References

  • The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study. Tissue plasminogen activator for acute ischemic stroke. N. Engl. J. Med.333, 1581–1587 (1995).
  • Becker KJ, Brott TG. Approval of the MERCI clot retriever: a critical review. Stroke36, 400–403 (2005).
  • Haley EC Jr, Lewandowski C, Tilley BC, NINDS rt-PA Stroke Study Group. Myths regarding the NINDS rt-PA Stroke Trial: setting the record straight. Ann. Emerg. Med.30, 676–682 (1997).
  • Albers GW, Bates VE, Clark WM, Bell R, Verro P, Hamilton SA. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA283, 145–150 (2000).
  • Hill MD, Buchan AM, Canadian Alteplase for Stroke Effectiveness Study (CASES) Investigators. Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study. CMAJ172, 1307–1312 (2005).
  • Heuschmann PU, Berger K, Misselwitz B et al. The German Stroke Registers Study Group and for the competence net stroke. Frequency of thrombolytic therapy in patients with acute ischemic stroke and risk of in-hospital mortality. Stroke34, 1106–1113 (2003).
  • Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA282, 2019–2026 (1999).
  • The ATLANTIS, ECASS, and NINDS rt-PA Study Group Investigators. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet363, 768–774 (2004).
  • Ribo M, Molina CA, Rovira A et al. Safety and efficacy of intravenous tissue plasminogen activator stroke treatment in the 3- to 6-hour window using multimodal transcranial Doppler/MRI selection protocol. Stroke36, 602–606 (2005).
  • The NINDS t-PA Stroke Study Group. Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA Stroke Trial. Stroke28, 2119–2125 (1997).
  • Smith WS, Sung G, Starkman S et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke36, 1432–1440 (2005).
  • Furlan A, Higishida R, Wechsler L et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA282, 2003–2011 (1999).
  • Gobin YP, Starkman S, Duckwiler GR et al. MERCI 1: a Phase I study of mechanical embolus removal in cerebral ischemia. Stroke35, 2848–2854 (2004).
  • Multi-MERCI Writing Committee for the Multi-MERCI Investigators. Safety of mechanical thrombectomy and intravenous t-PA in acute ischemic stroke. Results of the Multi-MERCI trial, Part I. Am. J. Neuroradiol. (2006) (In press).
  • Berlis A, Lutsep H, Barnwell S et al. Mechanical thrombolysis in acute ischemic stoke with EPAR (Endovascular Photoacoustic Recanalization). Stroke35, 1112–1116 (2004).
  • Ribo M, Alvarez-Sabin J, Montaner J et al. Temporal profile of recanalization after intravenous tissue plasminogen activator: selecting patients for rescue reperfusion techniques. Stroke37, 1000–1004 (2006).
  • Alexandrov AV, Grotta JC. Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology59, 862–867 (2002).
  • The IMS Investigators. Preliminary results of IMS II Trial. Stroke37, 708 (2006).
  • Mahon BR, Nesbit GM, Barnwell SL et al. North American clinical experience with the EKOS microlysis infusion catheter for the treatment of embolic stroke. Am. J. Neuroradiol.24, 534–538 (2003).
  • Alexandrov AV, Moline CA, Grotta JC et al. The CLOTBUST Investigators. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N. Engl. J. Med.351, 2170–2178 (2004).
  • Daffertshofer M, Gass A, Ringleb P et al. Transcranial low-frequency ultrasound-mediated thrombolysis in brain ischemia: increased risk of hemorrhage with combined ultrasound and tissue plasminogen activator. Results of a Phase II clinical trial. Stroke36, 1441–1446 (2005).
  • Lees KR, Zivin JA, Ashwood T et al. NXY-059 for acute ischemic stroke. N. Engl. J. Med.354, 588–600 (2006).
  • Adams RJ, Adams RJ, Brott T et al. Guidelines for the early management of patients with ischemic stroke: a scientific statement from the stroke council of the American Stroke Association. Stroke34, 1056–1083 (2003)

Websites

  • Embolectomy for clot removal after acute stroke. www.ClinicalTrials.gov Accessed May 27, 2006
  • Microbubbles and Ultrasound in Stroke Trial. www.ClinicalTrials.gov Accessed May 27, 2006
  • Intravenous thrombolysis plus hypothermia for acute treatment of ischemic stroke. www.ClinicalTrials.gov Accessed May 27, 2006
  • Field Administration of Stroke Therapy – MagnesiumTrial www.ClinicalTrials.gov Accessed May 27, 2006.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.